Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.48)
# 1,043
Out of 4,339 analysts
302
Total ratings
43.5%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Maintained: Buy | $266 | $137.30 | +93.74% | 3 | May 20, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $34 → $13 | $6.38 | +103.76% | 9 | May 18, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $15 | $4.26 | +252.11% | 2 | May 13, 2026 | |
| HROW Harrow | Maintained: Buy | $91 → $88 | $33.00 | +166.67% | 6 | May 12, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $46 | $29.68 | +54.99% | 5 | May 12, 2026 | |
| IFRX InflaRx | Maintained: Buy | $2 → $4 | $2.61 | +53.26% | 27 | May 8, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $7 | $4.50 | +55.56% | 7 | May 8, 2026 | |
| ABCL AbCellera Biologics | Initiated Coverage: Buy | $7 | $5.20 | +34.62% | 1 | May 5, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $105 → $100 | $30.89 | +223.73% | 32 | Apr 30, 2026 | |
| PRQR ProQR Therapeutics | Maintained: Buy | $8 | $1.56 | +412.82% | 11 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $22.46 | +42.48% | 5 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.26 | +342.48% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.57 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $26.37 | +51.69% | 2 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1,130 | $316.00 | +257.59% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $22 | $11.61 | +89.49% | 7 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $43 | $11.31 | +280.19% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $35.44 | +38.26% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $8.29 | +213.63% | 3 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $297.45 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $5.80 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $103 | $134.36 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.76 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $17 | $4.36 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $51 | $86.48 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $56 | $17.37 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $77 | $98.62 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $1.20 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $2.96 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $78 | $12.60 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $78.89 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $517.26 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $5 | $0.2101 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $59.71 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $7.03 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.5801 | n/a | 10 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $6.06 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $193.76 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $50.36 | n/a | 12 | Jun 13, 2021 |
Belite Bio
May 20, 2026
Maintained: Buy
Price Target: $266
Current: $137.30
Upside: +93.74%
Wave Life Sciences
May 18, 2026
Maintained: Buy
Price Target: $34 → $13
Current: $6.38
Upside: +103.76%
Opus Genetics
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $4.26
Upside: +252.11%
Harrow
May 12, 2026
Maintained: Buy
Price Target: $91 → $88
Current: $33.00
Upside: +166.67%
Pharvaris
May 12, 2026
Reiterated: Buy
Price Target: $46
Current: $29.68
Upside: +54.99%
InflaRx
May 8, 2026
Maintained: Buy
Price Target: $2 → $4
Current: $2.61
Upside: +53.26%
Camp4 Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $7
Current: $4.50
Upside: +55.56%
AbCellera Biologics
May 5, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $5.20
Upside: +34.62%
Viking Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $105 → $100
Current: $30.89
Upside: +223.73%
ProQR Therapeutics
Apr 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.56
Upside: +412.82%
Apr 7, 2026
Maintained: Buy
Price Target: $32
Current: $22.46
Upside: +42.48%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.26
Upside: +342.48%
Apr 1, 2026
Maintained: Hold
Price Target: n/a
Current: $3.57
Upside: -
Mar 23, 2026
Maintained: Buy
Price Target: $40
Current: $26.37
Upside: +51.69%
Mar 17, 2026
Initiated Coverage: Buy
Price Target: $1,130
Current: $316.00
Upside: +257.59%
Mar 12, 2026
Rated: Buy
Price Target: $21 → $22
Current: $11.61
Upside: +89.49%
Feb 25, 2026
Reiterated: Buy
Price Target: $42 → $43
Current: $11.31
Upside: +280.19%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $35.44
Upside: +38.26%
Jan 12, 2026
Maintained: Buy
Price Target: $26
Current: $8.29
Upside: +213.63%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $297.45
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $22
Current: $5.80
Upside: n/a
Nov 8, 2024
Maintained: Buy
Price Target: $93 → $103
Current: $134.36
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.76
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $22 → $17
Current: $4.36
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $24 → $51
Current: $86.48
Upside: n/a
Jan 3, 2024
Maintained: Buy
Price Target: $27 → $56
Current: $17.37
Upside: n/a
Oct 18, 2023
Maintained: Buy
Price Target: $84 → $77
Current: $98.62
Upside: n/a
Jun 23, 2023
Maintained: Buy
Price Target: $25 → $17
Current: $1.20
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $33 → $35
Current: $2.96
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $94 → $78
Current: $12.60
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $78.89
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $517.26
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $15 → $5
Current: $0.2101
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $38
Current: $59.71
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $7.03
Upside: n/a
May 18, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.5801
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $18
Current: $6.06
Upside: n/a
Jul 22, 2021
Maintained: Hold
Price Target: n/a
Current: $193.76
Upside: n/a
Jun 13, 2021
Maintained: Sell
Price Target: n/a
Current: $50.36
Upside: n/a